ArticleOncoTargets and therapy2025

Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort.

Asim Farooq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.